![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, October 25, 2014 1:54:54 PM
We could get PR Monday . . . but perhaps delayed for several days, to gain more input from Canada Conference results. I read that DRIO reader was INTRODUCED @ CC. Be that true we have no real sales yet? The Canadian distributor (One to date only?), is at conference booth with DRIO.
As I mentioned before, a Medical Care provider from USA at the conference could receive a free sample of the reader and strips and take that back to USA and use it confidentially (privately) with a troubled target patient---in closed use treatment-of-choice . . . without FDA approval). The government cannot stop emergent treatment regimes, that are personally chosen between care provider and patient, suffering unusually from final-stage disease care trauma and emotional stress. The professional care giver has right to 'expand' patient care regime . . . if deemed necessary to bring a further measure of comfort to such patients. This type of USA DRIO device use would be the minimum standard that FDA would accept (similar to 'orphan drug approval').
FDA might go that path initially (to await further patient-care giver interaction datum), as additional 'paper' for its Approval status. We just do not know yet.
USA FDA device status approval is like asking for nuclear device sanction, to stop an approaching menacing near-earth body?
Went to Canadian Diabetes Conference site and found no direct mention of DRIO as say speaker at conference.
However; our company did present as booth displayer.
Site MYDARIO.COM has two comments from device users from GB and NZ.
Found another site called MYDRIO.INVESTORROOM.COM and at bottom of page there is some stuff listed under CLINICAL TRIALS heading.
MAYBE RELATIVE TO USA TIME FRAME LAUNCH (?) . . . the following . . .
30th Annual Clinical Conference On Diabetes
May 21-24, 2015
Orlando Florida
We should all relax and just wait . . . unless DRIO can provide order info from CC . . . not much will happen with our immediate stock price movement or charting. We are, for all intends and purposes, rather unknown to investment world. That's OK . . . we get a slow-and-steady awareness mode. I am not worried.
Also see PFE has number of $$ drug bread winners going off patent soon . . . hopefully they will be looking for some new avenues of $$s profits. Though . . . instead PFE chose to buy back shares and keep twittering and having closed door BOD meetings of importance. PFE does not have much love for 'devices' or electronic medication.
They reside in the pill and lotion realm.
Don't worry . . . DRIO will get noticed . . . diabetes and its care . . . is major field for some company wanting to boost its bottom line. As long as folks do not exercise and there is large unemployed segment of population that butt-sets and eats western junk food diet . . . we have future care market bubble developing. <---large part of diabetes is inactivity and terrible food calorie intake . . . diabetes does have a genetic component and an emotional cause component (stress and worry), but that can often be managed. Inflamatory processes are also at heart of most disease. A happy personal outlook towards life and self is big benefit to healthful living?
Look for .05-.20 PR effect stock price movement possibility . . . what do the star charts say? I am on the Highway To Heaven? Or, The ROAD To He-el? What does the cosmic paint foretell?
Recent DRIO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:02:27 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:01:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 12:30:15 PM
- Empowering Commercial Expansion: DarioHealth Announces Strategic Reorganization and Appoints Inaugural Chief Commercial Officer • PR Newswire (US) • 06/05/2024 12:30:00 PM
- DarioHealth Reports First Quarter 2024 Financial and Operating Results • PR Newswire (US) • 05/15/2024 10:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 10:06:09 AM
- DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th • PR Newswire (US) • 05/07/2024 12:30:00 PM
- Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes • PR Newswire (US) • 04/25/2024 12:30:00 PM
- Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution • PR Newswire (US) • 04/18/2024 12:30:00 PM
- Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health • PR Newswire (US) • 04/10/2024 12:30:00 PM
- Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health • PR Newswire (US) • 04/02/2024 12:30:00 PM
- DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results • PR Newswire (US) • 03/28/2024 10:30:00 AM
- DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH • PR Newswire (US) • 03/21/2024 12:30:00 PM
- New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications • PR Newswire (US) • 03/12/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:24:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:23:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:21:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:20:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:19:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:16:57 PM
- DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE • PR Newswire (US) • 02/28/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:05:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:16:56 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM